Talphera, Inc. (TLPH) stock
TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.00 (-0.10%)
Close on Nov 18, 2026Market cap $41.52MP/E –Yield –
Talphera revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Talphera's revenue for the twelve months ending Jun 30, 2026 was $1.00K, down 96.3% year over year. For fiscal 2025 it was $28.00K. Over ten years it grew -48.0% a year on average. The highest annual figure on record is $29.50M in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.00K | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $651.00K | – |
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $2.82M | -48.0% |
| FY2020 | Dec 31, 2020 | $5.42M | +136.6% |
| FY2019 | Dec 31, 2019 | $2.29M | +6.4% |
| FY2018 | Dec 31, 2018 | $2.15M | -73.1% |
| FY2017 | Dec 31, 2017 | $8.00M | -53.9% |
| FY2016 | Dec 31, 2016 | $17.36M | -9.9% |
| FY2015 | Dec 31, 2015 | $19.26M | +269.2% |
| FY2014 | Dec 31, 2014 | $5.22M | -82.3% |
| FY2013 | Dec 31, 2013 | $29.50M | +1132.3% |
| FY2012 | Dec 31, 2012 | $2.39M | +123.3% |
| FY2011 | Dec 31, 2011 | $1.07M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $1.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $27.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $281.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $117.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $253.00K | -42.8% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $442.00K | -13.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.00K | -99.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.86M | +36.1% |
| Q2 FY2021 | Jun 30, 2021 | $443.00K | -84.8% |
| Q1 FY2021 | Mar 31, 2021 | $511.00K | +32.4% |
| Q4 FY2020 | Dec 31, 2020 | $738.00K | +55.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.37M | +125.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.92M | +210.7% |
| Q1 FY2020 | Mar 31, 2020 | $386.00K | +45.7% |
| Q4 FY2019 | Dec 31, 2019 | $475.00K | -22.5% |
| Q3 FY2019 | Sep 30, 2019 | $608.00K | +61.3% |
| Q2 FY2019 | Jun 30, 2019 | $941.00K | +15.0% |
| Q1 FY2019 | Mar 31, 2019 | $265.00K | -22.7% |
| Q4 FY2018 | Dec 31, 2018 | $613.00K | -17.2% |
| Q3 FY2018 | Sep 30, 2018 | $377.00K | -74.6% |
| Q2 FY2018 | Jun 30, 2018 | $818.00K | -69.2% |
| Q1 FY2018 | Mar 31, 2018 | $343.00K | -89.0% |
| Q4 FY2017 | Dec 31, 2017 | $740.00K | -88.5% |
| Q3 FY2017 | Sep 30, 2017 | $1.49M | -55.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.66M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.11M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.44M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.37M | – |
See a number that looks wrong?